Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy (NCT05990426)
The Impact of Alternate Day Fasting After Surgery for Patients Undergoing chemoTherapy (FAST Study)
🩺 Plain-English Summary (8th-Grade Level)
Endometrial cancer is the most common gynecologic cancer and ovarian cancer is the most lethal. The management of both advanced cancers is a combination of chemotherapy and surgery. Standard of care chemotherapeutic treatment for uterine and ovarian cancers is toxic and severely disruptive to the patient's quality of life with the potential for devastating short and long-term side effects. The role of fasting and ketogenic diets has been evaluated in a mixed cancer population and previously shown to be safe. There is no data specifically addressing the impact of a fasting diet regimen on side effects of chemotherapy during treatment for ovarian and endometrial cancers in the front-line setting. The information gathered from this study will inform future trials about the role of time-restricted eating and its impact on side-effects associated with chemotherapy as well as its role in improvement of quality of life for women afflicted with these debilitating diseases.
Who can join: Review the eligibility criteria below.
Location: Northwestern Memorial Hospital — Chicago, Illinois
Age range: 18 Years
🧪 Interventions in This Study
- FAST Intervention (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Northwestern Memorial Hospital — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (312) 503-4165
Email: anne@northwestern.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ovary Cancer
- Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study — Knoxville, Tennessee
- Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) — Chicago, Illinois
- Multimedia Aid for Genetic Testing in Gynecologic Oncology — Chapel Hill, North Carolina
- Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer — Baltimore, Maryland
- An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib — Irvine, California
Explore by condition: All Ovary Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.